![Su[fu] Antibody (F-4) - Western Blotting - Image 55082Each CRISPR/Cas9 Knockout (KO) Plasmid product consists of a pool of 3 plasmids designed to ensure identification and cleavage of a specific gene for maximum knockout efficiency. Each plasmid encodes a unique 20 nt sequence derived from the GeCKO (v2) library.](https://media.scbt.com/product/sufu-crispr-cas9-knockout-plasmid-m-western-blotting_05_50_b_55082.jpg)
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Su[fu] CRISPR/Cas9 KO Plasmid (m) | sc-423973 | 20 µg | $397.00 |
Suppressor of fused (Sufu) encodes the Su(fu) protein, a key negative regulator of Hedgehog signaling that restrains GLI transcription factor activity and helps control transcriptional programs governing embryonic patterning, cell fate specification, and tissue homeostasis. In mouse cells, SUFU functions as a cytoplasmic scaffold that sequesters GLI proteins and coordinates their processing and nuclear access, integrating with primary cilium–dependent Hedgehog pathway dynamics. Perturbation of Sufu can shift pathway output and downstream gene expression, making it relevant for studying developmental signaling logic and Hedgehog-driven cellular phenotypes. Altered SUFU function has been associated with dysregulated Hedgehog signaling in disease-related models, supporting its use as a mechanistic node for pathway interrogation.
Su[fu] CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sufu gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sufu together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sufu open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Su[fu] protein expression.
This CRISPR knockout system enables efficient generation of Sufu-deficient cell models for investigation of Su[fu] signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.